V624A
Category 5 — IDR ExclusionConflictingTransmembrane · predictedEditorialValine → Alanine at position 624 in connecting loop. ClinVar Conflicting including WFS1 spectrum. AlphaMissense 0.16 (below threshold) — AM under-call. DynaMut2 ΔΔG +0.13 (neutral). pLDDT 47 — IDR boundary.
Interactive 3D Structure
Bond changes · DynaMut2 interaction analysis
| Interaction type | Wild-type partner | Mutant partner | Status |
|---|---|---|---|
| Hydrogen bond | V620 | V620 | Preserved |
| Hydrogen bond | — | V621 | Gained |
| Hydrogen bond | L627 | L627 | Preserved |
| Hydrogen bond | T628 | T628 | Preserved |
| Polar contact | V620 | V620 | Preserved |
| Polar contact | V621 | V621 | Preserved |
| Polar contact | S626 | — | Lost |
| Polar contact | L627 | L627 | Preserved |
| Polar contact | T628 | T628 | Preserved |
| Van der Waals | S626 | S626 | Preserved |
| Van der Waals | L627 | — | Lost |
Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.
Computational Predictions
Clinical Evidence
Observed at very low frequency in gnomAD.
Structural Context
Position 624 at pLDDT 47 — BELOW the 50 threshold for trustworthy structure. Neighbors: MET623 (2.5 Å), LYS625 (2.5 Å), VAL621 (3.8 Å).
V624A conservative volume reduction in a disordered region. Computational predictions deserve caution. AM 0.16 under-call; WFS1 spectrum documented.
Druggability Assessment
The Atlas routes Category 5 variants to wet-lab characterization rather than computational drug discovery.
Why this matters
Feed this card to Wolfram Intelligence
Download the V624A PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.